Factors Affecting Post-treatment Outcomes in Patients With Hepatocellular Carcinoma
Condition: Hepatocellular Carcinoma Interventions: Device: Radiofrequency ablation; Drug: Trance-arterial chemoembolization; Procedure: Liver resection; Combination Product: Combined radiofrequency ablation + percutaneous ethanol injection; Drug: Percutaneous ethanol injection; Drug: Systemic chemotherapy; Drug: Sor afenib; Dietary Supplement: Viscum; Drug: Symptomatic treatment Sponsor: Sohag University Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Carcinoma | Chemotherapy | Hepatocellular Carcinoma | Liver Cancer | Nutrition | Research